Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCT

NCT02144025 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Graft-Versus-Host Disease

Interventions

DRUG: Cyclosporine

Sponsor

Hospital Universitario Dr. Jose E. Gonzalez